Welcome to our dedicated page for Axon Enterprise SEC filings (Ticker: AXON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Axon Enterprise鈥檚 mission to build a connected public-safety operating system spans everything from TASER devices to cloud SaaS, and that breadth shows up in dense SEC documents. If you鈥檝e ever tried to track how Software & Sensors subscription revenue moves against TASER hardware margins or wanted clarity on potential product-liability litigation, the 250-page annual report can feel overwhelming.
Stock Titan turns those pages into plain English. Our AI-powered summaries highlight what matters in every Axon annual report 10-K simplified, flagging segment revenue swings, deferred subscription backlog, and regulatory risk factors. Need the latest Axon quarterly earnings report 10-Q filing? We post it the moment it hits EDGAR and layer on instant earnings report filing analysis, so you see gross-margin trends before the call even starts. AG真人官方-time alerts surface Axon insider trading Form 4 transactions, letting you monitor executive stock transactions Form 4 without refreshing EDGAR. Material contract wins or product recalls appear in an Axon 8-K material events explained card, and the proxy statement executive compensation section is broken down so you can compare pay to performance.
Whether you鈥檙e screening for Axon Form 4 insider transactions real-time, trying to understand Axon SEC documents with AI, or simply searching for 鈥�Axon SEC filings explained simply,鈥� this page keeps every filing type鈥�10-K, 10-Q, 8-K, 4, S-8, 13G鈥攊n one place. You鈥檒l find:
- AI-generated key takeaways and risk flags
- Downloadable original documents and redlined updates
- Searchable table to filter by filing type or date
Save hours and make decisions faster with complete, continuously updated coverage of Axon鈥檚 regulatory disclosures, all distilled into insights you can act on.
Ardelyx (ARDX) has filed an 8-K detailing three material events.
Item 2.02 鈥� Results of Operations: Q2-25 financial results were released separately as Exhibit 99.1; the filing itself contains no revenue, EPS or guidance figures.
Item 5.02 鈥� Executive Transition: CFO/COO Justin Renz will leave the role on the earlier of 31 Dec 2025 or 30 days after a new CFO begins. Under an August 1, 2025 Transition Agreement he will (i) remain on current salary, benefits and 2025 bonus eligibility (individual component fixed at 100%) through the separation date and (ii) receive change-in-control severance and a 12-month post-separation option exercise window, subject to customary release and compliance conditions.
Item 5.03 鈥� Governance Changes: The Board adopted Second Amended & Restated Bylaws effective August 1. Key revisions tighten shareholder proposal procedures (record-holder requirement, 67% solicitation threshold, nominee cap), update quorum language, drop physical shareholder-list production, introduce a forum-selection clause and make other technical edits.
No other business, transactions or financial statements were reported.
On June 30, 2025, Indivior PLC (Nasdaq/LSE: INDV) filed a Form 8-K to furnish information under Item 7.01 (Regulation FD). The company reported, via an attached press release (Exhibit 99.1), that its ordinary shares have been selected for inclusion in both the U.S. Russell 2000 and Russell 3000 indexes. The filing contains no financial statements, earnings figures, or operational updates; it strictly communicates the index-membership development. While purely informational, index inclusion typically broadens a company鈥檚 investor base and can enhance share liquidity because passive funds that track the Russell family of indexes are required to purchase constituent stocks. No additional material events, transactions, or strategic changes are disclosed in this report.
Axon Enterprise, Inc. (AXON) 鈥� Form 4 insider transaction summary: President Joshua Isner reported two transactions involving AXON common stock. On 16-Jun-2025, 680 shares were disposed under transaction code F (shares withheld to cover income-tax obligations triggered by restricted stock unit (RSU) vesting) at a price of $780.63 per share. On 17-Jun-2025, Isner sold 905 shares in the open market at $776.39 per share under a pre-arranged Rule 10b5-1 trading plan adopted on 21-Aug-2024.
Following these actions, Isner鈥檚 direct beneficial ownership declined from 270,320 shares to 268,735 shares, a reduction of roughly 0.6 % of his total position and an immaterial fraction of Axon鈥檚 ~74 million shares outstanding. No derivative securities were involved and no new options were granted or exercised. The filing indicates routine tax withholding and modest portfolio diversification rather than a strategic divestiture. Because the sales were both limited in size and executed under a 10b5-1 plan, the market impact is expected to be neutral to modestly negative.
FAQ
What is the current stock price of Axon Enterprise (AXON)?
What is the market cap of Axon Enterprise (AXON)?
What is the core business of Axon Enterprise?
How does Axon generate revenue?
What are the main product categories offered by Axon?
How does Axon support law enforcement agencies?
What makes Axon鈥檚 technology innovative?
How is Axon integrated into modern public safety systems?
Who are the typical customers of Axon Enterprise?
